Thermo FisherTMO

Deutsche Bank raised its price target for the company from $635 to $720. This move suggests the firm sees more room for the stock to rise from its current level of about $673. While this is a notable increase, the firm did not change its overall rating on the stock. The new target is now well above the average analyst target of $631, reflecting a more optimistic view than many other Wall Street firms.

Source: Deutsche Bank

Thermo Fisher launched a new line of media and feeds, which are the specialized liquids and nutrients used to grow cells in a laboratory. These specific products are designed for CHO-K1 cells, a common workhorse used by drug companies to manufacture biologics, which are complex medicines made from living organisms. While a single product launch is routine for a company this size, it supports the core "razor and blade" business model. By selling the essential supplies that labs need every day to keep their experiments running, the company builds a steady stream of recurring revenue that lasts long after the initial lab equipment is sold.

Source: Business Wire

UBS set a new price target of $730 for the stock on Tuesday. This is notably higher than the average analyst target of $623 and suggests the firm sees more room for the stock to rise from its current price of about $645. While a target change on its own is routine, it reflects growing confidence that the company is moving past a recent slowdown in biotechnology spending. This aligns with recent results showing a return to growth as laboratory customers begin to spend more freely again.

Source: UBS

CLSA set a target for the stock at $748 on Thursday. This is notably higher than the $613.78 where the stock currently trades and the $613 average target from other analysts.

A price target is an analyst's estimate of where the stock will be in a year. While targets change often, this high estimate suggests CLSA sees more room for the company to grow than most of its peers do.

Source: CLSA

The company launched the Multiskan Ease, a new device used by scientists to measure how much light a liquid sample absorbs. This is a standard way to check protein levels or monitor how fast bacteria are growing in a lab. This launch adds to the company's massive catalog of lab equipment. These tools are important because they often require specific chemicals and supplies to run, which creates a steady stream of recurring sales after the initial machine is sold.

Source: Business Wire

Metrics we are tracking